Tissue distribution of 35S-labelled perfluorooctane sulfonate (PFOS) in C57Bl/6 mice following late gestational exposure

Reproductive Toxicology

Volumn 30, Issue 4, 2010, Pages 558-565

  Borg, D ^a   Bogdanska, J ^b   Sundstrom M ^b   Nobel, S ^b   Hakansson H ^a   Bergman, A ^b   DePierre, J W ^b   Halldin, K ^a   Bergstrom U ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b STOCKHOLM UNIVERSITY   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

Autoradiography; C57Bl 6 mouse; Liquid scintillation counting; Perfluoroalkylated compounds (PFCs); Perfluorooctane sulfonate (PFOS); Perinatal; Tissue distribution

Indexed keywords

PERFLUOROOCTANESULFONIC ACID; SULFUR 35;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; BONE DEVELOPMENT; BRAIN LEVEL; BRAIN TISSUE; CONTROLLED STUDY; FEMALE; FETUS; GESTATIONAL AGE; HARDER GLAND; INTESTINE; ISOTOPE LABELING; KIDNEY CORTEX; KIDNEY MEDULLA; KIDNEY PARENCHYMA; LIQUID SCINTILLATION COUNTING; LIVER; LIVER LEVEL; LUNG PARENCHYMA; MATERNAL BLOOD; MOTHER; NEWBORN; NONHUMAN; NOSE; PLACENTAL TRANSFER; PRENATAL EXPOSURE; PROGENY; STOMACH; TISSUE DISTRIBUTION; TISSUE LEVEL; WHOLE BODY AUTORADIOGRAPHY; YOLK SAC;

ALKANESULFONIC ACIDS; ANIMALS; ANIMALS, NEWBORN; BRAIN; ENVIRONMENTAL POLLUTANTS; FEMALE; FETAL BLOOD; FETUS; FLUOROCARBONS; KIDNEY; LIVER; LUNG; MATERNAL EXPOSURE; MATERNAL-FETAL EXCHANGE; MICE; MICE, INBRED C57BL; PREGNANCY; SCINTILLATION COUNTING; SULFUR RADIOISOTOPES; TISSUE DISTRIBUTION; WHOLE BODY IMAGING;

MUS; RODENTIA;

EID: 78649481561     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reprotox.2010.07.004     Document Type: Article

References (64)

1. 3M Company Fluorochemical use, distribution and release overview. U.S. EPA Administrative Records 226-0550 1999.
2. Kissa E. Specific applications, section 8.3. Fluorinated surfactants and repellants 2001, Marcel Decker, New York, p. 352-79. 2nd ed.
3. OECD. Hazard assessment of perfluorooctane sulfonate and its salts. ENV/JM/RD(2002)17/FINAL.
4. Key B.D., Howell R.D., Criddle C.S. Fluorinated organics in the biosphere. Environ Sci Technol 1997, 31(9):2445-2454.
5. Giesy J.P., Kannan K. Global distribution of perfluorooctane sulfonate in wildlife. Environ Sci Technol 2001, 35(7):1339-1342.
6. Yamashita N., Kannan K., Taniyasu S., Horii Y., Petrick G., Gamo T. A global survey of perfluorinated acids in oceans. Mar Pollut Bull 2005, 51(8-12):658-668.
7. Martin J.W., Smithwick M.M., Braune B.M., Hoekstra P.F., Muir D.C.G., Mabury S.A. Identification of long-chain perfluorinated acids in biota from the Canadian Arctic. Environ Sci Technol 2004, 38(2):373-380.
8. Calafat A.M., Needham L.L., Kuklenyik Z., Reidy J.A., Tully J.S., Aguilar-Villalobos M., et al. Perfluorinated chemicals in selected residents of the American continent. Chemosphere 2006, 63(3):490-496.
9. Kärrman A., Mueller J.F., van Bavel B., Harden F., Toms L-ML, Lindström G. Levels of 12 perfluorinated chemicals in pooled australian serum, collected 2002-2003, in relation to age, gender, and region. Environ Sci Technol 2006, 40(12):3742-3748.
10. Harada K., Koizumi A., Saito N., Inoue K., Yoshinaga T., Date C., et al. Historical and geographical aspects of the increasing perfluorooctanoate and perfluorooctane sulfonate contamination in human serum in Japan. Chemosphere 2007, 66(2):293-301.
11. EU Directive 2006/122/EC of the European Parliament and of the Council. Off J Eur Union 2006, L372:32-34.
12. USEPA Perfluoroalkyl sulfonates, significant new use rule; final rule. United States Federal Register 2002, 67(236):72854-72867.
13. United Nations Environment Programme Report of the conference of the parties of the Stockholm convention on persistent organic pollutants on the work of its fourth meeting 2009, UNEP/POPS/COP.4/38.
14. OECD Results of survey on production and use of PFOS, PFAS and PFOA, related substances and products/mixtures containing these substances 2005, ENV/JM/MONO 2005(1).
15. United Nations Environment Programme Consideration of new information on perfluorooctane sulfonate (PFOS) 2008, UNEP/POPS/POPRC.4/INF/17.
16. Lau C.S., Butenhoff J.L., Rogers J.M. The developmental toxicity of perfluoroalkyl acids and their derivatives. Toxicol Appl Pharmacol 2004, 198(2):231-241.
17. Grasty R.C., Wolf D.C., Grey B.E., Lau C.S., Rogers J.M. Prenatal window of susceptibility to perfluorooctane sulfonate-induced neonatal mortality in the Sprague-Dawley rat. Birth Defects Res B: Dev Reprod Toxicol 2003, 68:465-471.
18. Grasty R.C., Bjork J.A., Wallace K.B., Wolf D.C., Lau C.S., Rogers R.J. Effects of prenatal perfluorooctane sulfonate (PFOS) exposure on lung maturation in the perinatal rat. Birth Defects Res B: Dev Reprod Toxicol 2005, 74:405-416.
19. Abbott B.D., Wolf C.J., Das K.P., Zehr R.D., Schmid J.E., Lindstrom A.B., et al. Developmental toxicity of perfluorooctane sulfonate (PFOS) is not dependent on expression of peroxisome proliferator activated receptor-alpha (PPAR alpha) in the mouse. Reprod Toxicol 2009, 27(3-4):258-265.
20. Lehmler H.J., Xie W., Bothun G.D., Bummer P.M., Knutson B.L. Mixing of perfluorooctanesulfonic acid (PFOS) potassium salt with dipalmitoyl phosphatidylcholine (DPPC). Colloids Surf B: Biointerfaces 2006, 51:25-29.
21. Johnson J.D., Ober R.F. Absorption of FC-95-14C in rats after a single oral dose. U.S. EPA Administrative Records 226-0007 1979.
22. Austin M.E., Badrinarayanan S.K., Barber M., Kannan K., MohanKumar P.S., MohanKumar S.M.J. Neuroendocrine effects of perfluorooctane sulfonate in rats. Environ Health Persp 2003, 111(12):1485-1489.
23. Johnson J.D., Gibson S.J., Ober R.E. Extent and route of excretion and tissue distribution of total carbon-14 in rats after a single i.v. dose of FC-95-14C. U.S. EPA Administrative Records 8EHQ-1180-00374 1979.
24. Johnson J.D., Gibson S.J., Ober R.E. Cholestyramine-enhanced fecal elimination of carbon-14 in rats after administration of ammonium [14C]perfluorooctanoate or potassium [14C]perfluorooctanesulfonate. Fund Appl Toxicol 1984, 4:972-976.
25. Olsen G.W., Burris J.M., Ehresman D.J., Froehlich J.W., Seacat A.M., Butenhoff J., et al. Half-life of serum elimination of perfluorooctanesulfonate,perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Perspect 2007, 115(9):1298-1305.
26. Luebker D.J., Case M.T., York R.G., Moore J.A., Hansen K.J., Butenhoff J.L. Two-generation reproduction and cross-foster studies of perfluorooctanesulfonate (PFOS) in rats. Toxicology 2005, 215:126-148.
27. Inoue K., Okada F., Ito R., Kato S., Sasaki S., Nakajima S., et al. Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: assessment of PFOS exposure in susceptible population during pregnancy. Environ Health Perspect 2004, 112:1204-1207.
28. Kärrman A., Ericson I., van Bavel B., Darnerud P.O., Aune M., Glynn A., et al. Exposure of perfluorinated chemicals through lactation: levels of matched human milk and serum and a temporal trend, 1996-2004, in Sweden. Environ Health Perspect 2007, 115:226-230.
29. Ehresman D.J., Froehlich J.W., Olsen G.W., Chang S.C., Butenhoff J.L. Comparison of human whole blood, plasma, and serum matrices for the determination of perfluorooctanesulfonate (PFOS), perfluorooctanoate (PFOA), and other fluorochemicals. Environ Res 2007, 103(2):176-184.
30. Calafat A.M., Kuklenyik Z., Reidy J.A., Caudill S.P., Tully J.S., Needham L.L. Serum concentrations of 11 polyfluoroalkyl compounds in the U.S. population: data from the national health and nutrition examination survey (NHANES). Environ Sci Technol 2007, 41(7):2237-2242.
31. Olsen G.W., Church T.R., Miller J.P., Burris J.M., Hansen K.J., Lundberg J.K., et al. Perfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors. Environ Health Perspect 2003, 111(16):892-901.
32. Olsen G.W., Church T.R., Larson E.B., van Belle G., Lundberg J.K., Hansen K.J., et al. Serum concentrations of perfluorooctanesulfonate and other fluorochemicals in an elderly population from Seattle, Washington. Chemosphere 2004, 54(11):1599-1611.
33. Olsen G.W., Church T.R., Hansen K.J., Burris J.M., Butenhoff J.L., Mandel J.H., et al. Quantitative evaluation of perfluorooctanesulfonate (PFOS) and other fluorochemicals in the serum of children. J Child Health 2004, 2(1):53-76.
34. Toms L.M., Calafat A.M., Kato K., Thompson J., Harden F., Hobson P., et al. Polyfluoroalkyl chemicals in pooled blood serum from infants, children, and adults in Australia. Environ Sci Technol 2009, 43(11):4194-4199.
35. Calafat A.M., Wong L.-Y., Kuklenyik Z., Reidy J.A., Needham L.L. Polyfluoroalkyl chemicals in the U.S. population: Data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparison with NHANES 1999-2000. Environ Health Perspect 2007, 115(11):1596-1602.
36. Haug L.S., Thomsen C., Becher G. Time trends and the influence of age and gender on serum concentrations of perfluorinated compounds in archived human samples. Environ Sci Technol 2009, 43(6):2131-2136.
37. Olsen G.W., Mair D.C., Church T.R., Ellefson M.E., Reagen W.K., Boyd T.M., et al. Decline in perfluorooctanesulfonate and other polyfluoroalkyl chemicals in American red cross adult blood donors, 2006-2006. Environ Sci Technol 2008, 42(13):4989-4995.
38. Kärrman A., Domingo J.L., Llebaria X., Nadal M., Bigas E., van Bavel B., et al. Biomonitoring perfluorinated compounds in Catalonia, Spain: concentrations and trends in human liver and milk samples. Environ Sci Pollut Res Int 2010, 17(3):750-758.
39. Liu J., Li J., Luan Y., Zhao Y., Wu Y. Geographical distribution of perfluorinated compounds in human blood from Liaoning province, China. Environ Sci Technol 2009, 43(11):4044-4048.
40. Ullberg S., Larsson B. Whole-body autoradiography. Methods Enzymol 1981, 77:64-80.
41. Lau C., Thibodeaux J.R., Hanson R.G., Rogers J.M., Grey B.E., Stanton M.E., et al. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II. Postnatal evaluation. Toxicol Sci 2003, 74:382-392.
42. Luebker D.J., York R.G., Hansen K.J., Moore J.A., Butenhoff J.L. Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in Sprague-Dawley rats: dose-response, and biochemical and pharmacokinetic parameters. Toxicology 2005, 215:149-169.
43. Lau C., Anitole K., Hodes C., Lai D., Pfahles-Hutchens A., Seed J. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci 2007, 92:366-394.
44. Rosen M.B., Schmid J.E., Das K.P., Wood C.R., Zehr R.D., Lau C. Gene expression profiling in the liver and lung of perfluorooctane sulfonate-exposed mouse fetuses: comparison to changes induced by exposure to perfluorooctanoic acid. Reprod Toxicol 2009, 27(3-4):278-288.
45. Peroni D.G., Boner A.L. Atelectasis: mechanisms, diagnosis and management. Paediatr Res Rev 2000, 1(3):274-278.
46. Yahia D., Tsukuba C., Yoshida M., Sato I., Tsuda S. Neonatal death of mice treated with perfluorooctane sulfonate. J Toxicol Sci 2008, 33:219-226.
47. Cui L., Zhou Q.F., Liao C.Y., Fu J.J., Jiang G.B. Studies on the toxicological effects of PFOA and PFOS on rats using histological observation and chemical analysis. Arch Environ Contam Toxicol 2009, 56(2):338-349.
48. Chang S.C., Ehresman D.J., Bjork J.A., Wallace K.B., Parker G.A., Stump D.G., et al. Gestational and lactational exposure to potassium perfluorooctanesulfonate (K+PFOS) in rats: toxicokinetics, thyroid hormone status, and related gene expression. Reprod Toxicol 2009, 27(3-4):387-399.
49. Thibodeaux J.R., Hanson R.G., Rogers J.M., Grey B.E., Barbee B.D., Richards J.H., et al. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I. Maternal and prenatal evaluations. Toxicol Sci 2003, 74(2):369-381.
50. Lau C., Thibodeaux J.R., Ehresman D.J., Tanaka S., Froehlich J., Butenhoff J.L. Evaluation of perfluorooctanesulfonate (PFOS) in rat brain. Poster presentation. Fluoros Symposium 2005, http://www.chem.utoronto.ca/symposium/fluoros/pdfs/TOX020Lau.pdf. Accessed 13.01.2010.
51. Johansson N., Fredriksson A., Eriksson P. Neonatal exposure to perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) causes neurobehavioural defects in adult mice. NeuroToxicology 2008, 29(1):160-169.
52. Butenhoff J.L., Ehresman D.J., Chang S.C., Parker G.A., Stump D.G. Gestational and lactational exposure to potassium perfluorooctanesulfonate (K+PFOS) in rats: developmental neurotoxicity. Reprod Toxicol 2009, 27(3-4):319-330.
53. Era S., Harada K.H., Toyoshima M., Inoue K., Minata M., Saito N., et al. Cleft palate caused by perfluorooctane sulfonate is caused mainly by extrinsic factors. Toxicology 2009, 256(1-2):42-47.
54. Seyama Y., Kasama T., Yasugi E., Park S., Kano K. Lipids in Harderian glands and their significance. Harderian glands. Porphyrin metabolism, behavioral and endocrine effects 1992, 195-217. Springer-Verlag, Berlin. S.M. Webb, R.A. Hoffman, M.L. Puig-Domingo, R.J. Reiter (Eds.).
55. Luebker D.J., Hansen K.J., Bass N.M., Butenhoff J.L., Seacat A.M. Interactions of fluorochemicals with rat liver fatty acid-binding protein. Toxicology 2002, 176(3):175-185.
56. Midasch O., Drexler H., Hart N., Beckmann M.W., Angerer J. Transplacental exposure of neonates to perfluorooctanesulfonate and perfluorooctanoate: a pilot study. Int Arch Occup Environ Health 2007, 80(7):643-648.
57. Monroy R., Morrison K., Teo K., Atkinson S., Kubwabo C., Stewart B., et al. Serum levels of perfluoroalkyl compounds in human maternal and umbilical cord blood samples. Environ Res 2008, 108(1):56-62.
58. Olsen G.W., Hansen K.J., Stevenson L.A., Burris J.M., Mandel J.H. Human donor liver and serum concentrations of perfluorooctanesulfonate and other perfluorochemicals. Environ Sci Technol 2003, 37(5):888-891.
59. Maestri L., Negri S., Ferrari M., Ghittori S., Fabris F., Danesino P., et al. Determination of perfluorooctanoic acid and perfluorooctanesulfonate in human tissues by liquid chromatography/single quadrupole mass spectrometry. Rapid Commun Mass Spectrom 2006, 20(18):2728-2734.
60. Fanucchi M.V., Plopper C.G. Pulmonary developmental responses to toxicants. Comprehensive toxicology 1997, vol. 8:203-220. Pergamon, New York.
61. Lau C., Kavlock R.J. Functional toxicity in the developing heart, lung, and kidney. Developmental toxicology 1994, 119-188. Raven Press, New York. 2nd ed. C.A. Kimmel, J. Buelke-Sam (Eds.).
62. Pinkerton K.E., Joad J.P. The mammalian respiratory system and critical windows of exposure for children's health. Environ Health Perspect 2000, 108(3):457-462.
63. Plopper C.G., Fanucchi M.V. Do urban environmental pollutants exacerbate childhood lung diseases?. Environ Health Perspect 2000, 108(6):A252-A253.
64. Kajekar R. Environmental factors and developmental outcomes in the lung. Pharmacol Ther 2007, 114(2):129-145.